Karius
PrivateLast Round
Series C
May 2, 2024
Total Funding Raised
$345M
Company Overview
Karius is a biotechnology company that specializes in genomic testing for infectious diseases by providing advanced molecular biology tools that analyze microbial DNA from blood samples to assist physicians in making swift, life-saving treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Karius Comps
Public and private peers based on sector, stage, and business model.
Karius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 2, 2024 | ||||
| Series B | Feb 24, 2020 | ||||
| Debt | Nov 29, 2018 | ||||
| Series A | Aug 7, 2017 | ||||
| Seed | Sep 1, 2014 |
Karius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series C, Series B |
| Waycross Ventures | Series C |
| Khosla Ventures | Series B, Series A, Series C |
| S28 Capital | Series A |
| Innovation Endeavors | Series C, Series A |
| SoftBank Vision Fund 2 | Series C, Series B |
| SoftBank Group | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Karius Focus BAL test identifies 500 pathogens from BAL fluid.
- Oct 1, 2025
Karius Spectrum identifies over 1,000 pathogens from a single blood sample.
Karius Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Karius's valuation, stock price, and market status.
